Crossref
TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier
Arterial Hypertension · 2025
DOI: 10.5603/ah.108127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arterial Hypertension, 2025. Verfasst von Shobana Kumar und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kumar, S., Govindaraju, K., Kadir, S. Z. S. A., Majeed, A. B. A., Jamil, A. H. A., & Rahim, N. A. (2025). TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier. Arterial Hypertension. https://doi.org/10.5603/ah.108127
Vancouver
Kumar S, Govindaraju K, Kadir SZSA, Majeed ABA, Jamil AHA, Rahim NA. TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier. Arterial Hypertension. 2025. doi:10.5603/ah.108127
BibTeX
@article{Kumar2025,
author = {Kumar, Shobana and Govindaraju, Kayatri and Kadir, Sharifah Zamiah Syed Abdul and Majeed, Abu Bakar Abdul and Jamil, Amira Hajirah Abd and Rahim, Nusaibah Abdul},
title = {TRPC3 and TRPC6 as molecular mediators of resistant hypertension and cardiac fibrosis: a new therapeutic frontier},
journal = {Arterial Hypertension},
year = {2025},
doi = {10.5603/ah.108127}
}
EUVIMED